Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Lung and Upper Aerodigestive Cancer
Sponsor
Mayo Clinic
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00343629
RATIONALE: Giving healthy volunteers sulindac capsules or sulindac tablets may help doctors learn which form of the drug may be more effective in preventing cancer.
PURPOSE: This randomized clinical trial is studying sulindac capsules to see how well they work compared with sulindac tablets in healthy volunteers.
PURPOSE: This randomized clinical trial is studying sulindac capsules to see how well they work compared with sulindac tablets in healthy volunteers.
Intervention
pharmacological study, sulindac
Condition
Unspecified Adult Solid Tumor, Protocol Specific
Investigators
Paul J. Limburg, MD, MPH